Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioreactor Controls-III01:22

Bioreactor Controls-III

67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Upstream Processing01:27

Upstream Processing

97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Vaccine Production01:23

Vaccine Production

144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-term Outcomes of the Management of Chronic Refractory Ocular Allergy Using Allergen Immunotherapy.

Cornea·2026
Same author

Retraction notice to "p38 Mitogen-activated protein kinase modulates cisplatin resistance in head and neck squamous cell carcinoma cells" [Archives of Oral Biology 122 (2021)104981].

Archives of oral biology·2026
Same author

Elucidating the genetic landscape of inherited retinal disorders in India.

Human genomics·2026
Same author

Comparative transcriptomic analysis of retinal response to diverse cellular stresses reveals relative contributions of different cell death processes and signalling networks.

Cell death & disease·2025
Same author

Multivariate Process Optimization for Fixed-Bed Bioreactor-Based AAV Production Improves Total Batch Yield.

Human gene therapy·2025
Same author

Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2025
Same journal

Impact of an Artificial Albumin Corona on Surface Charge-Driven Nano-Bio Interactions and Cytotoxicity of Silver Nanoparticles.

ACS omega·2026
Same journal

Structural and Functional Disruption of Thiopurine S‑Methyltransferase by the A80P Variant: A Simulation and Genotyping Study.

ACS omega·2026
Same journal

CRISPR/Cas12a2-Mediated Ultrasensitive Assay for Rapid Detection of H1N1 Influenza Virus RNA.

ACS omega·2026
Same journal

Photocatalytic Treatment of Real Sugar Industry Wastewater Using Lignocellulosic Biomass-Derived Hydrochar/g-CN.

ACS omega·2026
Same journal

Electrochemical Dopamine Biosensor Based on Plant-Derived Peroxidase Immobilized on Titanate Nanowires.

ACS omega·2026
Same journal

Revealing the Effects of Process Parameters on Structural, Thermal, Mechanical, Biodegradation, and Biocompatibility Properties on the Electrospinning of Poly(vinyl alcohol)/Microbial Inulin Nanofibers.

ACS omega·2026
查看所有相关文章

相关实验视频

Updated: May 5, 2026

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

36.8K

用不同的加工方法改善不同血清型的AAV生产产量和质量.

Ashish Khaparde1, Riya Patra1,2, Shomereeta Roy1

  • 1GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore 560099, India.

ACS omega
|June 16, 2025
PubMed
概括
此摘要是机器生成的。

最大限度地提高腺相关病毒 (AAV) 产量对于基因疗法可访问性至关重要. 这项研究优化了AAV净化,表明亲和色谱显著改善了AAV生产的恢复和质量.

更多相关视频

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

9.7K
Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

1.9K

相关实验视频

Last Updated: May 5, 2026

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

36.8K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

9.7K
Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production
05:51

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

1.9K

科学领域:

  • 基因治疗 基因治疗
  • 生物技术是生物技术.
  • 病毒载体生产病毒载体生产

背景情况:

  • 基因相关病毒 (AAV) 是关键的基因疗法载体,其潜力仅限于生产产量.
  • 目前实验室规模的AAV产量在10^12-10^14vgc/L之间,影响成本和可访问性.
  • 优化上游和下游流程对于提高AAV生产效率至关重要.

研究的目的:

  • 为了比较两个净化方法 (CsCl超离心和亲和柱色谱) 进行腺相关病毒 (AAV) 恢复.
  • 优化AAV产量,评估对产品质量和传导效率的影响.
  • 提高整体生产能力,降低基于AAV的基因疗法的成本.

主要方法:

  • 使用粘附细胞制造工艺用于AAV生产.
  • 从细胞溶解物 (CsCl超离心) 和介质上浮物 (亲和染色) 中比较AAV的净化.
  • 使用这两种方法,对AAV6,AAV8和AAV9血清类型的量化净化AAV产量.

主要成果:

  • 获得的综合收益率为2.25 × 10^13 (AAV6),1.11 × 10^14 (AAV8) 和7.32 × 10^13 (AAV9) vg/L.
  • 亲属性染色学从介质上游生物中获得更高的百分比恢复 (AAV6: 88.35%,AAV8: 96.67%,AAV9: 93.54%) 的结果.
  • 与之前的报告相比,AAV9的产量增加了1.5倍;染色体学也改善了转导率.

结论:

  • 亲和染色法是AAV净化的一种优越方法,提供更高的回收和更好的产品质量.
  • 优化的净化策略显示了大幅扩大AAV生产能力的潜力.
  • 对血清型特异性化pH的进一步研究可以进一步完善AAV净化过程.